News

Fierce Pharma2d
Consumer health giant Kenvue kicks off CEO transition as sales slip
With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...
Kenvue stock rises on CEO exit as company launches strategic review and warns of lower sales
Kenvue, the Johnson & Johnson spinoff that owns brands such as Tylenol and Benadryl, announced Monday that Chief Executive ...
US stocks drift mostly higher as Nvidia leads gains for tech
U.S. stocks are drifting mostly higher following some mixed data on inflation and profits at some of the biggest U.S. banks ...
Asian shares mostly decline as worries continue over Trump's tariffs
Asian shares are trading mostly lower as worries about President Donald Trump’s latest updates to his tariffs weighed on ...
Renuncia CEO de Kenvue mientras la empresa sigue con su revisión estratégica
Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con ...
Schaeffer's Investment Research3d
Call Traders Circle Tylenol Parent Amid C-Suite Swap
Echoing this, short-term traders are also sporting a call-bias. This is per the security's Schaeffer's put/call open interest ...